MedTrace Logo

Robotic Exoskeleton Assisted Gait Post Stroke

NCT04309305 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-04-06

No results posted yet for this study

Summary

The current investigation takes advantage of both a progressive and adaptive assist-as-needed massed practice and time-sensitive neuroplasticity through exoskeleton assisted walking in order to induce greater recovery-oriented CNS plasticity and consequent gains in more independent walking.

Conditions

  • CVA
  • Gait, Hemiplegic

Interventions

DEVICE

EksoGT™, Ekso Bionics, Berkley, CA, USA

The Robotic Exoskeleton is a device that will be strapped to the chest and legs and worn over the shoulders like a backpack that will assist in walking.

OTHER

Standard of Care

Standard gait therapy provided by licensed physical therapists post stroke.

OTHER

No Intervention

Testing Only

Sponsors & Collaborators

  • Kessler Foundation

    lead OTHER

Principal Investigators

  • Karen J. Nolan, PhD · Kessler Foundation

  • Soha Saleh, PhD · Kessler Foundation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2026-05-01
Completion
2026-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04309305 on ClinicalTrials.gov